Optimization of a transient antibody expression platform towards high titer and efficiency,Biotechnology Journal

当前位置： X-MOL 学术 › Biotechnol. J. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Optimization of a transient antibody expression platform towards high titer and efficiency
Biotechnology Journal ( IF 4.7 ) Pub Date : 2020-11-23 , DOI: 10.1002/biot.202000251
Elizabeth Greene ₁ , Daniela Cazacu ₁ , Ninkka Tamot ₂ , Steven Castellano ₃ , Akshita Datar ₁ , Anthony Kronkaitis ₁ , Douglas Gebhard ₁ , Jon Reed ₁ , Paul Mawson ₁ , Lore Florin ₄ , Nicholas Rossi ₅ , Anthony Lauer ₅ , Laura Juckem ₅ , Andrew Nixon ₁ , Till Wenger ₁ , Saurabh Sen ₁

Affiliation

Transient gene expression (TGE) using mammalian cells is an extensively used technology for the production of antibodies and recombinant proteins and has been widely adopted by both academic and industrial labs. Chinese Hamster Ovary (CHO) cells have become one of the major workhorses for TGE of recombinant antibodies due to their attractive features: post‐translational modifications, adaptation to high cell densities, and use of serum‐free media. In this study, we describe the optimization of parameters for TGE for antibodies from CHO cells. Through a matrix evaluation of multiple factors including inoculum, transfection conditions, amount and type of DNA used, and post‐transfection culture conditions, we arrived at an uniquely optimized process with higher titer and reduced costs and time, thus increasing the overall efficiency of early antibody material supply. We further investigated the amount of coding DNA used in TGE and the influence of kinetics and size of the transfection complex on the in vitro efficiency of the transfection. We present here the first report of an optimized TGE platform using Filler DNA in an early drug discovery setting for the screening and production of therapeutic mAbs.

更新日期：2020-11-23

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>